IGFBP2 and coronary artery disorder: The BP1-BP2 microdeletion syndrome was reported to be associated with CHD as early as 2009 (Doornbos et al., 2009), but CHD occurrence may be underestimated in patients partly due to the characteristics of the deletion and partly due to the lack of cardiac monitoring following diagnosis.